Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 50/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Ap26113 |
Appearance | White Powder |
CAS NO. | 1197953-54-0 |
MF | C20H17N5O3 |
Storage | Keep in a cool, dry, dark location |
AP26113 is a versatile compound with significant potential in cancer therapy, research, and drug development. Its specific mode of action makes it a valuable tool in the fight against cancer and related diseases.
Cancer Therapy: AP26113 has shown potential in inhibiting the growth of certain cancer cells by targeting specific oncogenic pathways. Its ability to selectively block these pathways makes it a promising candidate for cancer treatment.
Research Tool: Due to its specificity and potency, AP26113 is also used as a research tool to investigate the mechanisms of cancer development and progression. It aids scientists in understanding the role of specific proteins and signaling pathways in cancer cells.
Drug Development: AP26113 serves as a lead compound in the development of new therapeutic agents for cancer and other related diseases. Its unique pharmacological profile provides a foundation for the design and synthesis of more effective and selective drugs.
Inhibition of Kinase Activity: AP26113 functions as a potent inhibitor of specific kinase enzymes, which are known to play critical roles in cell growth and division. By inhibiting these kinases, AP26113 disrupts the abnormal proliferation of cancer cells.
Modulation of Signaling Pathways: The compound modulates the activity of signaling pathways that are often deregulated in cancer. This modulation helps to restore normal cell function and growth regulation, thereby inhibiting cancer progression.
Induction of Cell Death: AP26113 has been shown to induce apoptosis, a programmed cell death process, in cancer cells. This function contributes to its antitumor activity by selectively eliminating cancer cells while sparing normal cells.